Regulatory agencies are putting increased emphasis on transparency, with the FDA holding its first public meeting on the topic and the EMEA seeking feedback from citizens on its draft policy.
The FDA's Nanotechnology Task Force released their report yesterday
including recommendations for how to address the regulatory
challenges posed by the increasing use of nanoscale materials.